Senate To Take Up FDA Drug-Safety, User-Fee Bill (Nasdaq)
WASHINGTON -(Dow Jones)- The U.S. Senate is scheduled to start debating a bill later Monday that would require the Food and Drug Administration to establish a safety system to monitor new drugs for at least three years after they have been approved.